| Serial Number | 97874080 |
| Word Mark | APRESYN |
| Filing Date | Wednesday, April 5, 2023 |
| Status | 730 - FIRST EXTENSION - GRANTED |
| Status Date | Wednesday, October 30, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, March 19, 2024 |
| Goods and Services | Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Saturday, April 8, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Teva Pharmaceuticals International GmbH |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Jona 8645 CH |
| Party Name | Teva Pharmaceuticals International GmbH |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Jona 8645 CH |
| Event Date | Event Description |
| Saturday, April 8, 2023 | NEW APPLICATION ENTERED |
| Saturday, April 29, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, January 1, 2024 | ASSIGNED TO EXAMINER |
| Monday, January 1, 2024 | NON-FINAL ACTION WRITTEN |
| Monday, January 1, 2024 | NON-FINAL ACTION E-MAILED |
| Monday, January 1, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, January 10, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, January 10, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, January 10, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, February 1, 2024 | FINAL REFUSAL WRITTEN |
| Thursday, February 1, 2024 | FINAL REFUSAL E-MAILED |
| Thursday, February 1, 2024 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Wednesday, February 14, 2024 | EXAMINERS AMENDMENT -WRITTEN |
| Wednesday, February 14, 2024 | EXAMINERS AMENDMENT E-MAILED |
| Wednesday, February 14, 2024 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Wednesday, February 14, 2024 | EXAMINER'S AMENDMENT ENTERED |
| Wednesday, February 14, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, February 28, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, February 28, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Wednesday, October 30, 2024 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, October 30, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, October 30, 2024 | SOU EXTENSION 1 GRANTED |
| Wednesday, October 30, 2024 | SOU EXTENSION 1 FILED |
| Tuesday, March 19, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, March 19, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, May 14, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |